These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine. Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J. Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477 [Abstract] [Full Text] [Related]
8. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats. Maeda A, Goto M, Zhang J, Bennet W, Groth CG, Korsgren O, Wennberg L. Transplantation; 2003 Apr 27; 75(8):1409-14. PubMed ID: 12717240 [Abstract] [Full Text] [Related]
9. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720. Suzuki S, Enosawa S, Kakefuda T, Amemiya H, Hoshino Y, Chiba K. Transplant Proc; 1996 Jun 27; 28(3):1375-6. PubMed ID: 8658701 [No Abstract] [Full Text] [Related]
12. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Tedesco-Silva H, Mourad G, Kahan BD, Boira JG, Weimar W, Mulgaonkar S, Nashan B, Madsen S, Charpentier B, Pellet P, Vanrenterghem Y. Transplantation; 2004 Jun 27; 77(12):1826-33. PubMed ID: 15223899 [Abstract] [Full Text] [Related]
13. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models. Nikolova Z, Hof A, Baumlin Y, Hof RP. Transpl Immunol; 2001 Feb 27; 8(4):267-77. PubMed ID: 11316070 [Abstract] [Full Text] [Related]
15. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Chiba K, Hoshino Y, Suzuki C, Masubuchi Y, Yanagawa Y, Ohtsuki M, Sasaki S, Fujita T. Transplant Proc; 1996 Apr 27; 28(2):1056-9. PubMed ID: 8623225 [No Abstract] [Full Text] [Related]
16. Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study. Kahan BD, Karlix JL, Ferguson RM, Leichtman AB, Mulgaonkar S, Gonwa TA, Skerjanec A, Schmouder RL, Chodoff L. Transplantation; 2003 Oct 15; 76(7):1079-84. PubMed ID: 14557756 [Abstract] [Full Text] [Related]
17. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Hoshino Y, Suzuki C, Ohtsuki M, Masubuchi Y, Amano Y, Chiba K. Transplant Proc; 1996 Apr 15; 28(2):1060-1. PubMed ID: 8623226 [No Abstract] [Full Text] [Related]
18. [Effect of mono and combination therapy with FTY720 and ICAM-1 mAb for mouse-to-rat cardiac xenotransplantation]. Xiong HB, Huang ZF, Ye QF, Xia SS. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb 15; 32(1):41-6. PubMed ID: 17344585 [Abstract] [Full Text] [Related]
19. Immunosuppressive therapy using FTY720 combined with tacrolimus in rat liver transplantation. Tamura A, Li XK, Funeshima N, Enosawa S, Amemiya H, Kitajima M, Suzuki S. Surgery; 2000 Jan 15; 127(1):47-54. PubMed ID: 10660758 [Abstract] [Full Text] [Related]
20. FTY720 immunomodulation: optimism for improved transplant regimens. Ferguson R. Transplant Proc; 2004 Mar 15; 36(2 Suppl):549S-553S. PubMed ID: 15041404 [Abstract] [Full Text] [Related] Page: [Next] [New Search]